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Background
Left ventricular noncompaction (LVNC) is classified by
the American Heart Association as a primary genetic car-
diomyopathy and is attributed to defects in cardiac embry-
ogenesis resulting in the intrauterine arrest of the
compaction of the loose meshwork that makes up the fetal
myocardium. From echocardiographic data, the prevalence
of LVNC has been estimated at 0.05% of the general popu-
lation. With the increasing use of cardiac magnetic reso-
nance imaging (CMR), there has been a surge in the
reports of patients with LVNC. Interestingly, many
patients that have been diagnosed with non-ischemic
dilated cardiomyopathy (NIDCM) have also been noted to
have prominent left ventricular trabeculations. We sought
to evaluate the difference in clinical outcomes in patients
with NIDCM compared to those with LVNC as diagnosed
by established CMR criteria.
Methods
A retrospective analysis was performed on 71 patients
diagnosed with NIDCM at a single tertiary care center
who had undergone a CMR between January 1, 2012 and
August 30, 2014. The diagnosis of cardiomyopathy was
established based on clinical suspicion and a dilated left
ventricle (LV) when indexed to body surface area. Baseline
characteristics and clinical outcomes were obtained. Volu-
metric quantification was performed to obtain chamber
volumes and ejection fractions (EF). The ratio of com-
pacted:non-compacted myocardium was measured at end-
diastole in both the 4- and 2-chamber orientations. The
data was analyzed using analysis of variance (ANOVA)
and Pearson’s chi squared testing with SPSS Statistics for
Windows.
Results
Of 71 patients, 25% were found to meet the criteria of
LVNC based on established CMR criteria. The mean age
of individuals diagnosed with LVNC was 50.9 years as
compared to 50.4 years (p=0.907). The incidence of prior
stroke, diabetes mellitus, hypertension, end-stage renal dis-
ease, and cancer treated with chemotherapy or radiation
did not differ between the two groups. The mean LVEF in
both groups was 36% (p=0.992). There was no statistical
difference in the mean number of heart failure admissions
when comparing patients with LVNC and NIDCM (0.83
vs. 0.73, p=0.747). Both groups exhibited similar occur-
rences of ventricular (p=0.473) and atrial arrhythmias
(p=0.204). For all patients, the most commonly trabecu-
lated areas were the anterior and lateral walls, while the
least was the septum. The apical segments were noted to
have the most prominent trabeculations.
Conclusions
This represents the largest study comparing the clinical
outcomes of those patients with MRI defined LVNC to
those with NIDCM. Our results demonstrate LVNC may1Cardiology, Loyola University, Chicago, IL, USA
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not be prognostically different than NIDCM, suggesting
that LVNC may be a morphological variant of NIDCM or
perhaps that the current CMR criteria for LVNC need to
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Table 1 Patient Comparison of LVNC and NIDCM
Individuals with ≥ 3 segments with non-
compacted:compacted ratio ≥ 2.3n = 18 (%)
Individuals with < 3 segments with non-




Males 7 (38.9) 32 (60.4)
Mean Age in Years 50.9 +/- 17.9 50.4 +/- 15.3 0.907
History of CVA 1 (5.6) 1 (1.9) 0.416
History of Diabetes Mellitus 4 (22.2) 16 (30.2) 0.516
History of Hypertension 9 (50) 27 (50.9) 0.945
History of ESRD 0 (0) 1 (1.9) 0.557
History of Cancer with Exposure to
Chemotherapy/Radiation
3 (16.7) 7 (13.2) 0.715
Outcomes:
Average Number of Heart Failure
Admissions per Patient
0.83 +/- 1.0 0.73 +/- 1.2 0.747
Thromboembolic Events 2 (11) 3 (5.7) 0.435
SVT 6 (33.3) 10 (18.9) 0.204
NSVT or VT 2 (11.1) 11 (20.8) 0.473
Underwent ICD Placement 6 (33.3) 10 (18.9) 0.393
Underwent LVAD placement 1 (5.6) 0 (0) 0.084
Underwent Heart Transplantation 0 (0) 0 (0) –
Mortality 0 (0) 1 (1.9) 0.557
CMR features:
LV EF (%) 36.0 +/- 17.9 36.1 +/- 12.7 0.992
LV End Diastolic Volume Index
(mL/m2)
139.0 +/- 49.0 122.0 +/- 41.4 0.157
LV End Systolic Volume Index (mL/
m2)
93.8 +/- 53.6 81.9 +/- 41.6 0.333
LV Mass Index (g/m2) 58.9 +/- 19.5 65.0 +/- 20.8 0.277
RV EF (%) 45.4 +/- 12.4 46.1 +/- 10.3 0.816
RV End Diastolic Volume Index
(mL/m2)
88.3 +/- 24.3 84.8 +/- 27.7 0.634
RV End Systolic Volume Index (mL/
m2)
47.6 +/- 22.6 47.1 +/- 22.5 0.927
LA Volume Index (mL/m2) 64.6 +/- 18.7 54.8 +/- 23.9 0.122
Data displayed as n (%) or mean +/- standard deviation. CVA = cerebrovascular accident. ESRD = end-stage renal disease. SVT = supraventricular tachycardia.
NSVT = non-sustained ventricular tachycardia. VT = ventricular tachycardia. ICD = implantable cardioverter defibrillator. LVAD = left ventricular assist device.
CMR= cardiac magnetic resonance imaging. LV = left ventricle. EF = ejection fraction. RV = right ventricle. LA = left atrium. Means compared with ANOVA.
Baseline characteristics and outcomes compared with Pearson’s chi squared testing.
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